Simon LOIODICE, based in France, is currently a Co-Founder and CEO at Karla Therapeutics, bringing experience from previous roles at NLC - The European Healthtech Venture Builder, Innoved Therapeutics and Biotrial. Simon LOIODICE holds a 2013 - 2016 Doctor of Philosophy (Ph.D.) @ Université d'Auvergne (Clermont-Ferrand I). With a robust skill set that includes Pharmacology, In Vivo, Life Sciences, Neuroscience, Toxicology and more, Simon LOIODICE contributes valuable insights to the industry. Simon LOIODICE has 5 emails on RocketReach.